Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-21

Clinical Trial Update: Prospective Study of Benznidazole for Chagas' Disease Children With Chronic Indeterminate Chagas Disease [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating benznidazole for children with chronic indeterminate Chagas disease; the trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Benznidazole (benznidazole)

Snippet

Sponsor: Insud Pharma | Conditions: Chagas Disease | Phase 3 | Status: ACTIVE_NOT_RECRUITING